Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort study. 2021

Maelle Le Bras, and Hélène Leclerc, and Olivia Rousseau, and Pierre Goudet, and Thomas Cuny, and Frederic Castinetti, and Catherine Bauters, and Philippe Chanson, and Antoine Tabarin, and Sebastien Gaujoux, and Sophie Christin-Maitre, and Philippe Ruszniewski, and Francoise Borson-Chazot, and Isabelle Guilhem, and Philippe Caron, and Bernard Goichot, and Albert Beckers, and Brigitte Delemer, and Isabelle Raingeard, and Bruno Vergès, and Sarra Smati, and Matthieu Wargny, and Bertrand Cariou, and Samy Hadjadj
CHU de Nantes PHU2 Institut du Thorax et du Système Nerveux, Service d'Endocrinologie, Diabétologie et Nutrition, Nantes, France.

OBJECTIVE Pituitary adenoma (PA) is one of the three major components of multiple endocrine neoplasia type 1 (MEN1). Recent studies have suggested that MEN1-associated PAs are less aggressive than initially estimated. We propose an analysis of the outcome of PAs with a standard of care treatment in a nationwide cohort of MEN1 patients. METHODS Retrospective observational nationwide cohort study using the MEN1 patient registry from the French Group of Endocrine Tumours (GTE). METHODS The GTE database population consists of 1435 patients with MEN1. This analysis focused on 551 patients recruited after 2000 with at least 3 years of follow-up. The study outcome was tumour progression of PA defined by an increase in Hardy classification (HC) during follow-up according to referring physician regular reports. RESULTS Among 551 MEN1 patients (index and related), 202 (36.7%) had PA, with 114 (56.4%) diagnosed by MEN1-related screening. PAs were defined according to HC as microadenoma (grade I) in 117 cases (57.9%), macroadenoma in 59 (29.2%) with 20 HC grade II and 39 HC grades III-IV and unspecified in 26 (12.8%). They were prolactinomas in 92 cases (45.5%) and non-secreting in 73 (36.1%). After a median follow-up of 3 years among the 137 patients with HC grades I-II, 4 patients (2.9%) presented tumour progression. CONCLUSIONS PAs in patients with MEN1 are less aggressive than previously thought. Tumour progression is rare with a standard of care monitoring and treatment, especially in related patients who mostly present non-secreting microadenoma. MRI monitoring for asymptomatic MEN1 patients should be reduced accordingly.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D018761 Multiple Endocrine Neoplasia Type 1 A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13). Neoplasia, Multiple Endocrine Type 1,Neoplasms, Multiple Endocrine Type 1,Wermer Syndrome,Multiple Endocrine Neoplasia Type I,Multiple Endocrine Neoplasms Type 1,Neoplasms, Multiple Endocrine Type I

Related Publications

Maelle Le Bras, and Hélène Leclerc, and Olivia Rousseau, and Pierre Goudet, and Thomas Cuny, and Frederic Castinetti, and Catherine Bauters, and Philippe Chanson, and Antoine Tabarin, and Sebastien Gaujoux, and Sophie Christin-Maitre, and Philippe Ruszniewski, and Francoise Borson-Chazot, and Isabelle Guilhem, and Philippe Caron, and Bernard Goichot, and Albert Beckers, and Brigitte Delemer, and Isabelle Raingeard, and Bruno Vergès, and Sarra Smati, and Matthieu Wargny, and Bertrand Cariou, and Samy Hadjadj
December 1990, Clinical endocrinology,
Maelle Le Bras, and Hélène Leclerc, and Olivia Rousseau, and Pierre Goudet, and Thomas Cuny, and Frederic Castinetti, and Catherine Bauters, and Philippe Chanson, and Antoine Tabarin, and Sebastien Gaujoux, and Sophie Christin-Maitre, and Philippe Ruszniewski, and Francoise Borson-Chazot, and Isabelle Guilhem, and Philippe Caron, and Bernard Goichot, and Albert Beckers, and Brigitte Delemer, and Isabelle Raingeard, and Bruno Vergès, and Sarra Smati, and Matthieu Wargny, and Bertrand Cariou, and Samy Hadjadj
January 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Maelle Le Bras, and Hélène Leclerc, and Olivia Rousseau, and Pierre Goudet, and Thomas Cuny, and Frederic Castinetti, and Catherine Bauters, and Philippe Chanson, and Antoine Tabarin, and Sebastien Gaujoux, and Sophie Christin-Maitre, and Philippe Ruszniewski, and Francoise Borson-Chazot, and Isabelle Guilhem, and Philippe Caron, and Bernard Goichot, and Albert Beckers, and Brigitte Delemer, and Isabelle Raingeard, and Bruno Vergès, and Sarra Smati, and Matthieu Wargny, and Bertrand Cariou, and Samy Hadjadj
December 2002, Endocrine journal,
Maelle Le Bras, and Hélène Leclerc, and Olivia Rousseau, and Pierre Goudet, and Thomas Cuny, and Frederic Castinetti, and Catherine Bauters, and Philippe Chanson, and Antoine Tabarin, and Sebastien Gaujoux, and Sophie Christin-Maitre, and Philippe Ruszniewski, and Francoise Borson-Chazot, and Isabelle Guilhem, and Philippe Caron, and Bernard Goichot, and Albert Beckers, and Brigitte Delemer, and Isabelle Raingeard, and Bruno Vergès, and Sarra Smati, and Matthieu Wargny, and Bertrand Cariou, and Samy Hadjadj
January 2022, Archives of medical science : AMS,
Maelle Le Bras, and Hélène Leclerc, and Olivia Rousseau, and Pierre Goudet, and Thomas Cuny, and Frederic Castinetti, and Catherine Bauters, and Philippe Chanson, and Antoine Tabarin, and Sebastien Gaujoux, and Sophie Christin-Maitre, and Philippe Ruszniewski, and Francoise Borson-Chazot, and Isabelle Guilhem, and Philippe Caron, and Bernard Goichot, and Albert Beckers, and Brigitte Delemer, and Isabelle Raingeard, and Bruno Vergès, and Sarra Smati, and Matthieu Wargny, and Bertrand Cariou, and Samy Hadjadj
March 1984, Presse medicale (Paris, France : 1983),
Maelle Le Bras, and Hélène Leclerc, and Olivia Rousseau, and Pierre Goudet, and Thomas Cuny, and Frederic Castinetti, and Catherine Bauters, and Philippe Chanson, and Antoine Tabarin, and Sebastien Gaujoux, and Sophie Christin-Maitre, and Philippe Ruszniewski, and Francoise Borson-Chazot, and Isabelle Guilhem, and Philippe Caron, and Bernard Goichot, and Albert Beckers, and Brigitte Delemer, and Isabelle Raingeard, and Bruno Vergès, and Sarra Smati, and Matthieu Wargny, and Bertrand Cariou, and Samy Hadjadj
February 2014, Pituitary,
Maelle Le Bras, and Hélène Leclerc, and Olivia Rousseau, and Pierre Goudet, and Thomas Cuny, and Frederic Castinetti, and Catherine Bauters, and Philippe Chanson, and Antoine Tabarin, and Sebastien Gaujoux, and Sophie Christin-Maitre, and Philippe Ruszniewski, and Francoise Borson-Chazot, and Isabelle Guilhem, and Philippe Caron, and Bernard Goichot, and Albert Beckers, and Brigitte Delemer, and Isabelle Raingeard, and Bruno Vergès, and Sarra Smati, and Matthieu Wargny, and Bertrand Cariou, and Samy Hadjadj
January 2001, Clinical endocrinology,
Maelle Le Bras, and Hélène Leclerc, and Olivia Rousseau, and Pierre Goudet, and Thomas Cuny, and Frederic Castinetti, and Catherine Bauters, and Philippe Chanson, and Antoine Tabarin, and Sebastien Gaujoux, and Sophie Christin-Maitre, and Philippe Ruszniewski, and Francoise Borson-Chazot, and Isabelle Guilhem, and Philippe Caron, and Bernard Goichot, and Albert Beckers, and Brigitte Delemer, and Isabelle Raingeard, and Bruno Vergès, and Sarra Smati, and Matthieu Wargny, and Bertrand Cariou, and Samy Hadjadj
January 2009, Hormone research,
Maelle Le Bras, and Hélène Leclerc, and Olivia Rousseau, and Pierre Goudet, and Thomas Cuny, and Frederic Castinetti, and Catherine Bauters, and Philippe Chanson, and Antoine Tabarin, and Sebastien Gaujoux, and Sophie Christin-Maitre, and Philippe Ruszniewski, and Francoise Borson-Chazot, and Isabelle Guilhem, and Philippe Caron, and Bernard Goichot, and Albert Beckers, and Brigitte Delemer, and Isabelle Raingeard, and Bruno Vergès, and Sarra Smati, and Matthieu Wargny, and Bertrand Cariou, and Samy Hadjadj
April 2024, Clinical cancer research : an official journal of the American Association for Cancer Research,
Maelle Le Bras, and Hélène Leclerc, and Olivia Rousseau, and Pierre Goudet, and Thomas Cuny, and Frederic Castinetti, and Catherine Bauters, and Philippe Chanson, and Antoine Tabarin, and Sebastien Gaujoux, and Sophie Christin-Maitre, and Philippe Ruszniewski, and Francoise Borson-Chazot, and Isabelle Guilhem, and Philippe Caron, and Bernard Goichot, and Albert Beckers, and Brigitte Delemer, and Isabelle Raingeard, and Bruno Vergès, and Sarra Smati, and Matthieu Wargny, and Bertrand Cariou, and Samy Hadjadj
November 2004, World journal of surgery,
Copied contents to your clipboard!